We use third-party cookies to provide support. By continuing to browse this website,
you accept our privacy policy.
Cabaletta Bio Inc
12 own
14 watching
Current Price
$3.3
$0.05
(1.38%)
1 Week Returns
3 Months Returns
1 Year Returns
Get Started with as little as $1.00
Market Capitalization
364.97M
52-Week High
26.35000
52-Week Low
1.76000
Average Volume
1.98M
Dividend Yield
--
P/E Ratio
--
Market Capitalization364.97M52-Week High26.3500052-Week Low1.76000Average Volume1.98MDividend Yield--P/E Ratio--What does the Cabaletta Bio Inc do?
Cabaletta Bio, Inc. is a clinical-stage biotechnology company. The Company is focused on the discovery and development of engineered T cell therapies that have the potential to provide deep and durable, perhaps curative, responses with one-time administration for patients with autoimmune diseases. Its Cabaletta Approach to B cell Ablation (CABA) platform encompasses two strategies: Chimeric Antigen Receptor T cells for Autoimmunity (CARTA) and Chimeric AutoAntibody Receptor T cells (CAART). CABA-201, its lead product candidate from its CARTA platform, is a 4-1BB co-stimulatory domain-containing fully human CD19-CAR T construct designed to treat patients with a range of autoimmune diseases. Its DSG3-CAART product candidate is being evaluated for the treatment of mPV, a subtype of PV that affects the epithelium of the mucous membranes, in the Phase 1 DesCAARTes TM trial. Its MuSK-CAART product candidate is designed to treat a subset of patients with MG, targeting autoreactive B cells.
Read More
How much money does Cabaletta Bio Inc make?
News & Events about Cabaletta Bio Inc.
Tickeron - Stocks
1 year ago
This indicator may be signaling CABA's price has momentum to move higher, since its current price moved above its price 14 days ago. Traders may consider buying the stock or exploring call options...
Tickeron - Stocks
1 year ago
Over the last three days, A.I.dvisor has detected that CABA's AroonUp green line (see chart) is above 70, while the AroonDown red line is below 30. When the green line goes above 70 while the red...
Stock Options Channel
1 year ago
Investors considering a purchase of Cabaletta Bio Inc (CABA) stock, but cautious about paying the going market price of 12.74/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the February 2024 ...
Globe Newswire
1 year ago
IND application cleared within 6 months of in-licensing CABA-201 binder CABA-201 data package and experience from prior autoimmune cell therapy INDs informed Phase 1/2 clinical trial design, including the initial dose to be evaluated and the patient dosing intervals PHILADELPHIA, March 31, 2023 (...
Ticker Report
1 year ago
Cabaletta Bio (NASDAQ:CABA Get Rating)s stock had its buy rating restated by equities research analysts at Chardan Capital in a research note issued on Wednesday, Benzinga reports. They currently have a $12.00 price objective on the stock. Chardan Capitals target ...
Frequently Asked Questions
Frequently Asked Questions
What is Cabaletta Bio Inc share price today?
Can Indians buy Cabaletta Bio Inc shares?
How can I buy Cabaletta Bio Inc shares from India?
Can Fractional shares of Cabaletta Bio Inc be purchased?
What are the documents required to start investing in Cabaletta Bio Inc stocks?
What is today’s traded volume of Cabaletta Bio Inc?
What is today’s market capitalisation of Cabaletta Bio Inc?
What is the 52-Week High and Low Range of Cabaletta Bio Inc?
What percentage is Cabaletta Bio Inc down from its 52-Week High?
What percentage is Cabaletta Bio Inc up from its 52-Week Low?
Current Price
$3.3
$0.05
(1.38%)
1 Week Returns
3 Months Returns
1 Year Returns
Get Started with as little as $1.00
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 500,000 who have signed up and are using Stockal successfully already.
Related Stocks
Sign up and dive into a whole new world of investing.
Join over 500,000 who have signed up and are using Stockal successfully already.